(Total Views: 509)
Posted On: 01/13/2021 2:36:41 AM
Post# of 153994
CCR5delta32 status should also be collected on HIV patients.
Heterozygous mutants should respond especially well to LL.
Its a shortcut to FDA approval.
Maybe the FDA can jerk you around on the main trial but the CCR5 mutants might be good off the charts.
Heterozygous mutants should respond especially well to LL.
Its a shortcut to FDA approval.
Maybe the FDA can jerk you around on the main trial but the CCR5 mutants might be good off the charts.
(1)
(0)
